An East Rand health insurance provider has emerged as central to the alleged unlawful importation of chloroquine. Affinity Health is now being investigated by the SA Health Products Regulatory Authority. Courtesy #DStv403
JOHANNESBURG - An East Rand health insurance provider has emerged central to the alleged unlawful importation of chloroquine.
Affinity Health is now being investigated by the South African Health Products Regulatory Authority.
This follows eNCA’s exclusive report last month which revealed several tons of malaria medication had slipped into the country.
Chloroquine has been touted as a COVID-19 treatment but some studies now indicate it may, in fact, cause harm.
Three independent sources have alleged that Affinity Health was dispensing the medication to staff as a COVID-19 preventative measure.
It has been further alleged that the company planned to distribute chloroquine to its network of pharmacies.
Affinity Health chief executive Murray Hewlett, through his lawyer, declined to comment on the matter.
SAHPRA also declined an interview but it is understood investigators are preparing to pursue the matter as a violation of the Sars Act.
Meanwhile, AFP reports that the World Health Organisation will resume clinical trials of hydroxychloroquine after it was suspended pending a safety review in the search for coronavirus treatments.
- Coronavirus Hotline Number: 0800 029 999 from 8am to 4pm, Monday to Friday
Help protect your loved ones by sharing this official South African government COVID-19 service with your family, friends and community.
Send HI to 0600 123 456 on WhatsApp.
The NICD has another Clinician Hotline to improve #COVID19 communication and support for healthcare providers. The Clinician Hotline is 0800 11 1131, operating 24 hrs. The Public Hotline is 0800 029 999 also operating 24hrs.